Chul Ahn

机构：Southwestern Medical Center, The University of Texas Southwestern Medical Center · ORCID：0000-0002-2997-9203

发表论文 745 篇 · 总被引 21477 次 · h-index 74

代表论文

Danburstotug, an anti‐ PD ‐ L1 antibody, in relapsed/refractory extra‐nodal natural killer/T‐cell lymphoma: The phase 2 DISTINKT study (2026 · British Journal of Haematology)
Supplementary Table 3 from Nonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell Transplants (2026)
Supplementary Table 4 from Nonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell Transplants (2026)
Supplementary Figure 2 from Nonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell Transplants (2026)
Supplementary Table 1 from Nonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell Transplants (2026)
Supplementary Table 5 from Nonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell Transplants (2026)